Sweden· SE-19970919000096
Optiray 240 mg I/ml Injektions-/infusionsvätska, lösning
A medicinal product containing ioversol, registered in Sweden by Guerbet.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ioversol
- Manufacturer
- Guerbet
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- July 30, 2026
Packs & prices · 1
- se_varunummer19970919000096
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ioversol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOptiject 240 mg I/mlGuerbet
- United KingdomOptiray 240 solution for infusion 100ml bottlesMallinckrodt UK Commercial Ltd
- CzechiaOPTIRAYGuerbet, Roissy CdG Cedex
- Japanイオベルソールゲルベ・ジャパン
- FinlandOptirayGuerbet
- SpainOPTIRAY 240 mg/ml SOLUCION INYECTABLEGuerbet
- United StatesOptirayLiebel-Flarsheim Company LLC
- IrelandOptiray 300 mg I/ml PFS solution for injectionGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Optiray
- Belgium · Optiject, Optiray
- Czechia · Optiray
- Germany · Optiray
- Denmark · Optiray
- Spain · Optiray, Optiray Ultraject
- Finland · Optiray
- France · Optiject, Optiray
- United Kingdom (Northern Ireland) · Optiray
- Greece · Optiray
- Croatia · Optiray
- Hungary · Optiray
- Ireland · Optiray
- Italy · Optiray
- Luxembourg · Optiject, Optiray
- Netherlands · Optiray
- Norway · Optiray
- Poland · Optiray
- Portugal · Optiray
- Romania · Optiray
- Slovakia · Optiray
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e833741-fda3-4c25-b038-96ab604367a5 GET /v1/drugs/4e833741-fda3-4c25-b038-96ab604367a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19970919000096",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19970919000096",
"product_doc_link": "https://docetp.mpa.se/LMF/Optiray%20240%20mg%20I%20per%20ml%20solution%20for%20injection%20or%20infusion%20ENG%20SmPC_09001bee82fa2e62.pdf"
}See everything about ioversol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.